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Abstract
Background: We investigate whether the extent of educational inequalities in the use of Pap smears (cervical
cancer screening) and mammograms (breast cancer screening) in Belgium has changed over time in accordance
with the pattern predicted by diffusion of innovation theory, as well as how the regional cancer screening policies
of Flanders and Wallonia influence this pattern.
Methods: Data were obtained from five successive cross-sectional waves (1997–2001–2004-2008-2013) of the
Belgian Health Interview Survey. Final sample sizes consisted of 8988 women aged 25–64 years for cervical cancer
screening and 4194 women aged 50–69 years for breast cancer screening. We calculated absolute and relative
measures of inequality, more specifically, the slope index of inequality (SII) and the relative index of inequality (RII),
and their development over time.
Results: In both Flanders and Wallonia, mammogram use increased greatly between 1997 and 2013, while Pap
smear use has remained quite stable over time. Educational inequalities in cervical-cancer screening have been
largely persistent over time in both regions. In contrast, educational inequalities in breast cancer screening
fluctuated more between 1997 and 2013. Between 1997 and 2001, when the breast cancer screening programme
was implemented in Flanders, RII reduced significantly by 45%. Inequality measures did not change significantly in
Wallonia, where it is known that most women are screened opportunistically outside the programme.
Conclusions: By focussing on Belgium, this study demonstrates that regional variations in the support of a national
screening programme can result in regional variations in the pattern of diffusion for cancer screening, as well as to
the development of inequalities in cancer screening participation. Moreover, the findings demonstrate that high
visibility and awareness of the screening programme, as was more the case in Flanders than it was in Wallonia,
are required in order to reduce or eliminate educational inequalities in cancer screening participation over time.
General practitioners and gynaecologists can play a decisive role in this regard.
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Background
Research has focused primarily on the facilitators and
barriers associated with participation in cancer screen-
ing, as well as on socioeconomic inequalities in the
uptake of screening tests [1–9]. Factors associated with
the gradual spread of cancer screening tests within a
population over time have received far less attention
[10]. As a result, developments in socioeconomic in-
equalities in the uptake and spread of screening tests
over time remain unclear. Diffusion of innovation (DOI)
theory offers a useful perspective for studying such
universal processes of social change. As suggested by
previous studies on health innovations, DOI theory can be
applied to cancer screening behaviour as well [10, 11].
According to DOI theory, new preventive technologies
or health interventions (e.g. cancer screening tests)
spread through a population in a predictable pattern re-
sembling an S-shaped curve [12, 13]. When a cancer
screening test is first introduced, only a few people will
adopt the innovation. In other words, only a few people
will use the screening test (these are the ‘early adopters’).
Later, as the rate of uptake accelerates and enough
people use the test (the ‘early majority’), the screening
will gain critical mass and become increasingly wide-
spread through the population. Finally, the increase in
uptake will decelerate, as fewer and fewer remaining po-
tential members of the population (the ‘late majority’
and ‘laggards’) will use the test. According to DOI the-
ory, the various categories of adopters are strongly asso-
ciated with socio-economic position [12, 13]. In fact,
early adopters tend to have a higher social status and
more years of education than do members of the late
majority or the laggards. Consequently, the diffusion of
an innovation follows a cycle of adoption in which, over
time, the innovation spreads through a population from
those with the highest level of education to those with
the lowest. As posited by the inverse equity hypothesis,
the first stage of the diffusion – in which a cancer
screening test has recently been introduced – is gener-
ally accompanied by a widening gap in use between
people with high and low levels of education, as the test
is likely to reach those with higher levels of education
first [14]. Only in a further diffusion stage, when the
more highly educated groups have reached threshold
levels of use and those with lower educational attain-
ment gain greater access to the screening test, will the
initially increasing educational gap once again start to
shrink. In summary, rates of participation in cancer
screening, as well as the associated educational inequal-
ities in use, tend to fluctuate over time along an
S-shaped curve.
Although previous research has consistently found
that women with higher levels of education are more
likely to participate in screening for cervical and breast
cancer, as compared to their counterparts with less edu-
cation [3, 5–7, 15–17], less attention has been paid to
how such educational gaps in cancer screening participa-
tion have developed over time. In addition, with a few
exceptions [10, 18, 19], DOI theory has not been applied
as a framework within which to explain time trends in
the unequal participation in cancer screening. As result,
cancer screening researchers have tended to overlook
the fact that different screening tests, which have been
introduced into clinical practice at different points in
time, are positioned at different stages in the diffusion
process, which are thus associated with different levels
of inequality [19]. Moreover, existing studies fail to
address the impact of cancer screening policies or
strategies on the diffusion pattern.
In general, cancer screening strategies can be categorised
as either ‘organised’ or ‘opportunistic’. In organised
screening, screening activities are carried out as part of an
organised programme, which requires [1] the active and
systematic identification and invitation of a defined target
population (i.e. the eligible screening population); [2] the
use of homogeneous criteria and quality-control activities
and [3] the evaluation of results and quality [20–22]. In
contrast, in opportunistic screening, screening tests are
offered only in primary or other healthcare settings. Their
use thus depends on the spontaneous initiative of patients
and their physicians. Given that the opportunistic ap-
proach does not systematically identify and invite the
eligible screening population, it is more likely to result in
variability in those who participate, as well as in the quality
of the screening process. Cancer screening strategies can
differ both between and within countries, depending on
the type of cancer being screened (e.g. breast, cervical).
Belgium offers an interesting case with which to study
the impact of screening strategies (organised vs. oppor-
tunistic) on the diffusion patterns of cancer screening
tests. First, given that different screening strategies are
applied for the screening of breast and cervical cancer in
Belgium, variations in usage according to screening
strategy might be visible. Second, given the clear
differences between Belgian regions with respect to the
organisation of cancer screening, regional variations
might occur even when the same screening strategy is
used. More specifically, the gradual cultural and social
divergence between the Dutch-speaking northern part
(Flanders) and the French-speaking southern part (Wallonia)
of Belgium gave rise to two separate political systems.
Within this complex political system, regional authorities are
charged with the organisation, management and evaluation
of cancer screening, with the Federal state retaining respon-
sibility primarily for the financing of most medical acts and
reimbursements. This situation has generated regional
differences in terms of organisation, management, promo-
tional activities, culture and prescription behaviour [4].
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In Belgium, breast cancer screening by means of
mammography (the process of using low-level X-rays to
examine the human breast for diagnosis and screening)
was introduced in the 1970s [23]. In 1987, the introduc-
tion of the EU programme ‘Europe against Cancer’
resulted in a generalisation of screening campaigns, and
the increased control associated with this programme
enhanced the homogeneity and quality of mammog-
raphy [24]. Until 2000, however, breast cancer screening
in Belgium lacked any consistent policy or strategy [25].
In fact, municipalities, provinces, and the Flemish and
Belgian governments independently carried out pro-
grammes to raise awareness about the importance of
breast cancer screening without proper coordination be-
tween such programmes. Since 2001 in Flanders and
since 2002 in Brussels and Wallonia, breast cancer
screening has been organised at the population level in a
national breast cancer screening programme, in line with
the European guidelines for quality assurance. In this
programme, every eligible woman between the ages of
50 to 69 years receives a personalised letter every two
years with a set appointment for a mammogram, which
is paid entirely and directly by the healthcare insurance
to the mammography unit [26]. In other words, the
mammogram is provided free of charge. Despite the na-
tionwide implementation and organisation of the screen-
ing programme, a wide gap exists between the Belgian
regions [27]. In Flanders, half of all women between the
ages of 50 and 69 years have had a mammograms
through the organised programme. In Wallonia and
Brussels, most women are screened outside the orga-
nised programme during consultations with their general
practitioners or gynaecologists. Efforts to organise a na-
tional screening programme notwithstanding, the oppor-
tunistic screening of breast cancer remains the most
common way of screening in the south of Belgium.
Despite EU [28] recommendations that cancer screening
should be offered only in organised, population-based pro-
grammes with quality assurance at all levels, cervical can-
cer screening in Belgium is not population-based, and it
remains essentially opportunistic. Since 1965, specialised
mobile teams or fixed centres have organised periodic
screening in Flanders. Due to low participation rates, how-
ever, this vertical system was abandoned in the early 1980s
and replaced by a gradual increase in opportunistic
screening by private gynaecologists and, to a lesser extent,
by general practitioners [29]. Although screening initia-
tives were set up in the Flemish provinces, efforts to start
a central cervical cancer screening programme have thus
failed so far [27]. In addition, the opportunistic cervical
screening in Belgium is characterised by a high level of
over-screening (i.e. the model screening interval is one year,
instead of the European guideline of three years) [27, 30].
Moreover, as is generally the case in the context of
over-screening, over-consumption has emerged only in one
part of the eligible population, while under-consumption
has occurred in the other part. More specifically, women
with high socio-economic status are screened more than
necessary, while older and more socio-economically
disadvantaged women are particularly likely to remain un-
screened [30, 31]. To address over-consumption, the gov-
ernments have gradually taken steps to reduce the
reimbursement of cervical cancer screening or ‘Papanico-
laou’ tests (also known as ‘Pap smears’). Prior to
2009, Pap smears were reimbursed once every year.
Between 2009 and 2013, they were reimbursed once
every two years and, since 2013, they have been reim-
bursed once every three years [27]. In contrast to
mammogram use, regional differences in Pap smear
use are less pronounced.
Government policies (e.g. the introduction of an
organised screening programme) can influence the diffu-
sion pattern and unequal use of cancer screening tests
[10]. More specifically, the implementation of a national
population-based programme for breast cancer screen-
ing in 2001–2002 might have reshaped the diffusion
pattern of mammogram use in Belgium. Screening pro-
grammes are aimed at addressing the drawbacks of
individual decision-making in opportunistic screening by
upscaling the screening process to the population level.
Benefits of this strategy include the systematic identifica-
tion and invitation of the population group at risk,
specific appointments, higher quality and full reimburse-
ment of the screening costs. Because of these benefits,
population-based programmes are better able to reduce
the education gradient in the use of cancer screening
tests [6, 7, 9, 20, 32, 33]. In other words, such screening
programmes can respond to and reshape the classic
diffusion pattern predicted by DOI theory. Previous stud-
ies by Puddu and colleagues [4] and by Renard and col-
leagues [5] have investigated whether the introduction of
the Belgian national programme for breast cancer screen-
ing reduced educational inequalities in mammogram use
over the periods 2001–2004 and 1997–2008, respectively.
These studies demonstrate that the screening programme
improved mammogram use by Belgian women, although
it did not completely counteract the education gradient in
use. Although the results of these two studies do reveal a
decreasing education gradient over time, the authors note
that this decline had apparently started before the intro-
duction of the programme. Because these studies do not
distinguish between regions, however, they are unable to
explore the possible role of the high rate of screening out-
side the programme in the regions Brussels and Wallonia
in the observed persistence of educational inequalities in
mammogram use.
The purpose of the present study is to investigate the
impact of regional screening policies in Belgium on the
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diffusion patterns of two different screening tests: Pap
smears (for cervical cancer screening) and mammograms
(for breast cancer screening). Both of these tests target
women, and both are characterised by relatively high
usage rates in Belgium [5, 26, 34, 35]. The screening strat-
egies applied for the two tests differ, however, with cervical
cancer screening being opportunistic, while breast cancer
screening is organised through a screening programme.
More specifically, this study focuses on how educational
inequalities in the use of mammograms and Pap smears
have developed over time, relative to the pattern predicted
by DOI theory and whether this pattern varies according
to regional differences in screening policies.
Methods
Study population and data
Data were obtained from five successive waves (1997,
2001, 2004, 2008 and 2013) of the Belgian Health Inter-
view Survey (BHIS). The repeated cross-sectional design
and consistent methodology (e.g. composition of the
sample, organisation of fieldwork) of the BHIS make it
possible to assess trends across the various years of the
survey and to evaluate the impact of the implementation
of the national breast cancer screening programme in
2001–2002 [36]. Households and their members were
selected from the National Register following a
multi-stage stratified sampling procedure. The informa-
tion was collected through face-to-face interviews, as
well as through a self-administered questionnaire. A
complete description of the methodological foundation
and evolution of the BHIS has been published by
Demarest and colleagues [36]. In the current study, we
adopted the final sample sizes according to the European
guidelines for the eligible screening population for each
cancer type: women between the ages of 25 and 64 years
for cervical cancer screening, and women between the
ages of 50 and 69 years for breast cancer screening. We
omitted all cases with missing information (N = 754;
5.6%), as well as cases having cancer at the time of the
interview (N = 246; 1.9%). This results in final samples of
8988 women for cervical cancer screening (N = 4405 in
Flanders, N = 4583 in Wallonia) and 4194 women for
breast cancer screening (N = 2075 in Flanders, N = 2119
in Wallonia). Data from Brussels were excluded from
our study, as the sample sizes per wave were too small
to provide meaningful analyses of inequalities across
educational groups.
Model variables
Dependent variables
Self-reported mammogram and Pap smear use were
considered as the dependent variables. Women were
asked whether they had undergone a mammogram in
the past two years and a cervical smear test in the past
three years (‘yes’ or ‘no’). The questionnaire did not dis-
tinguish between screening, diagnostic and follow-up
mammograms and Pap smears, nor between opportunis-
tic or programme-based screening.
Main independent variable
Educational attainment was measured as the highest
level of education completed. This information was
recoded into four categories, according to the Inter-
national Standard Classification of Education (ISCED
2011): 0 = no diploma/primary education, 1 = lower
secondary education, 2 = higher secondary education,
and 3 = tertiary education [37].
Potential confounding variables
As known from previous research, older women, women
from ethnic minority groups, women living in rural
areas, unemployed women and women with financial
difficulties tend to engage less in screening [38–42]. We
therefore controlled for age (categories vary across
screening tests), country of birth (0 = Belgium, 1 = not
Belgium), urbanisation (0 = urban, 1 = rural), employ-
ment status (0 = employed, 1 = not employed), necessity
of postponing medical consumption (0 = no, 1 = yes) and
difficulty contributing to healthcare (0 = not hard to pay,
1 = hard to pay).
Statistical analyses
First, Pap smear coverage (the proportion of women
aged 25–64 years who reported having had a Pap smear
in the past three years) and mammogram coverage (the
proportion of women aged 50–69 years who reported
having had a mammogram within the past two years)
was estimated for the five waves, broken down by region
and educational level. In addition, we created a graphic
display of the diffusion patterns of mammogram and
Pap smear use between 1997 and 2013 in Flanders and
Wallonia, overall and by educational attainment.
Second, to estimate the gradient of educational in-
equality in the use of mammograms and Pap smears, we
adopted both relative and absolute regression-based
measures of inequality that are recommended when
making comparisons over time or across populations:
the relative index of inequality (RII) and the slope index
of inequality (SII) [43, 44]. Both of these measures offer
the advantage of considering screening attendance in all
educational levels, along with the relative position and
size of each educational level within a population, in-
stead of merely comparing the two most extreme
groups. The measures are therefore able to take into ac-
count shifts occurring within the educational hierarchy
when results are compared over time. They are calcu-
lated by transforming educational level into a summary
measure that is scaled from 0 to 1 (representing the
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lowest and highest hypothetical level of education, re-
spectively). To reflect the share of the sample at each
educational level, the population in each education
category is assigned a modified ridit score on the scale,
based on the midpoint of the range in the cumulative
distribution of the population within a given category.
As suggested by Zou [45], we applied a ‘modified
Poisson regression’ approach to compute RII and SII
with 95% confidence intervals (CI), as this strategy offers
a solution for the convergence issues associated with the
binary approach and provides more robust estimates
than the binary approach does [43, 46]. A RII greater
than 1 and a positive SII imply that, compared to those
with less education, women with higher levels of
education are more likely to use the screening test. We
created graphs to display the diffusion patterns of
relative (RII) and absolute (SII) educational inequalities
between 1997 and 2013 in Flanders and Wallonia.
Third, to assess the development of RII and SII over
time, these estimates were compared between two differ-
ent survey years using the interaction test, as applied in
the method reported by Altman and Bland [47]. To cal-
culate the test, the difference of the two log odds ratios
or relative risks was divided by its standard error. The
corresponding p-value of the test was obtained on the
table of the z-distribution. All analyses were performed
with STATA 13, in order to account for the multistage
sampling design of the BHIS.
Results
Mammogram and Pap smear use in Flanders and
Wallonia between 1997 and 2013
As shown in Table 1 and Fig. 1a and Fig. 2a, the
diffusion patterns of mammogram and Pap smear use
exhibited strong differences. The diffusion pattern of
mammogram use was more in line with the diffusion
pattern predicted by DOI theory (Fig. 1a). More specific-
ally, between 1997 and 2013, mammogram use clearly
became increasingly widespread within the population of
women between the ages of 50 and 69 years. This pat-
tern was particularly visible in Flanders, where mammo-
gram coverage increased from 45.6 to 78.1% of the
women reporting having had a mammogram in the past
two years, although it was also observed in Wallonia,
where there was an increase from 51.2 to 69.7%. In
Wallonia, however, following a continuous rise since
1997, coverage declined from 76 to 69.7% between 2008
and 2013. In contrast, the diffusion pattern of Pap smear
use reflected hardly any change in use over time in ei-
ther region (Fig. 2a). In Flanders, there was a slight de-
crease in the number of women between the ages of 25
and 64 years who reported having had a Pap smear in
the past three years (from 74 to 70.8%), while Wallonia
exhibited a slight increase (from 64.1 to 76%).
Within each cancer screening test, diffusion patterns
varied according to educational level, as shown in Fig. 1b,
c and Fig. 2b, c. In general, in both regions, women with
higher levels of education showed a higher rate of mam-
mogram and Pap smear use than did their counterparts
with less education. The results revealed differences with
regard to developments in educational disparity in mam-
mogram and Pap smear use. With regard to mammogram
use, educational disparities transformed over time, seem-
ingly under the influence of regional screening policies. In
Flanders, before the introduction of the national screening
programme, considerably more women with high levels of
education reported having had a mammogram in the past
two years, as compared to those with low levels of educa-
tion (71% vs. 38.2%), although this disparity decreased
after 2001 (Fig. 1b). Surprisingly, this narrowed gap was
initially due to reduced mammogram use amongst women
who had completed tertiary education, combined with
increased use by women with less education. In Wallonia,
where the programme was implemented in 2002, different
diffusion patterns by educational level were observed
(Fig. 1c). In contrast to the situation in Flanders, the
introduction of the programme was initially accom-
panied by a widened education gradient in mammog-
raphy use. After 2004, however, the gap gradually
narrowed, due to decreases in use amongst women
with both the highest (from 84.9% in 2004 to 68.5%
in 2013) and lowest (from 67.4% in 2008 to 50.6% in
2013) levels of education. Unlike the developments
observed in the diffusion patterns of mammogram
use, except for a few slight fluctuations, Pap smear
use remained quite stable over time, regardless of
women’s educational level or region (Fig. 2b and c).
This nevertheless implies that, in both regions, the
education gradient in Pap smear use has also changed
very little over time.
Development of absolute and relative educational
inequalities in mammogram and Pap smear use
In a subsequent step, we investigated the statistical sig-
nificance of changes in absolute and relative inequalities
in mammogram and Pap smear use, both successive and
overall. Despite the national screening programme for
breast cancer, changes in educational inequalities in
mammogram use varied considerably by region. In
Flanders, relative educational inequalities in mammo-
gram use decreased significantly by 45% (p = 0.04)
between 1997 (RII = 2.09, 95% CI 1.32–3.31) and 2001
(RII = 1.15, 95% CI 0.84–1.37), when the national screen-
ing programme was launched (Table 2). This decline is
also clearly visible in Fig. 3a. The overall decrease of
relative educational inequalities by 39.2% between 1997
and 2013 was also significant (p = 0.05). Despite this sig-
nificant decline, in 2013, mammogram use in Flemish
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women with high levels of education was still 1.27 (95%
CI 1.03–1.56) times higher than the rate observed
amongst their counterparts with less education. In Wal-
lonia (Fig. 3a and b), the education gradient in mammo-
gram use increased between 1997 and 2001 (in contrast
to the decrease observed in Flanders during this period),
although the disparities also started to decline in Wallo-
nia. It is important to note that, in 1997, absolute and
relative inequalities were much lower in Wallonia than
they were in Flanders. As demonstrated by the signifi-
cance tests, however, neither the observed successive
changes nor the overall change in educational inequal-
ities were significant in Wallonia (Table 2). These results
suggest that, in Flanders, where women are more loyal
to the national breast cancer screening programme, the
education gradient decreased significantly after the im-
plementation of the programme, while it did not change
significantly in Wallonia, where women are more likely
to be screened outside the programme in an opportunis-
tic manner.
As shown in Table 2, educational inequalities in Pap
smear use were large and persistent in both regions be-
tween 1997 and 2013. In Flanders, RII increased signifi-
cantly by 26.4% (p = 0.05) between 2008 and 2013.
Moreover, there was an overall significant increase of
159.9% (p = 0.03) in absolute inequalities between 1997
Table 1 Self-reported mammogram use in women 50–69 years old within the past two years and self-reported Pap smear use in
women 25–64 years old within the past three years in Flanders and Wallonia, overall and by educational level, across the five waves
of the BHIS (1997-2013)
1997 2001 2004 2008 2013
N % N % N % N % N %
Mammogram use
Flanders
Overall 164 45.6 228 53.5 313 69.2 314 71.6 298 78.1
By educational level
None or primary 46 38.2 61 46 64 61.2 56 62.3 36 66.1
Lower secondary 45 40.2 78 60.7 81 66.3 84 77.4 61 77.5
Higher secondary 42 47.1 56 53.1 102 75.5 90 68.2 119 77.3
Tertiary 31 71 33 56.3 66 73.7 84 78.1 82 85.8
Wallonia
Overall 189 51.2 287 64 372 73 280 76 285 69.7
By educational level
None or primary 61 42.5 79 54.3 79 56.2 50 67.4 36 50.6
Lower secondary 50 49.5 92 67.3 92 68.8 72 77.6 37 79.5
Higher secondary 42 62.1 57 64.3 92 81.4 84 76.8 87 75.6
Tertiary 36 57.2 59 75.9 109 84.9 74 79.3 95 68.5
Pap smear use
Flanders
Overall 660 74 709 71.5 693 70.4 584 68.5 553 70.8
By educational level
None or primary 85 60.4 80 60 44 42.4 44 44.9 22 53
Lower secondary 140 71.1 131 61.4 118 63.4 85 61.3 63 59.5
Higher secondary 223 75.5 243 72.7 257 74 201 71 190 63.9
Tertiary 212 80.5 255 81.9 274 79.4 254 75.9 278 81.9
Wallonia
Overall 546 64.1 669 64.5 790 73.9 608 75.7 589 76
By educational level
None or primary 60 44 76 50.6 77 55.1 48 57.6 31 51.2
Lower secondary 126 56.6 168 66.1 152 65.9 106 76.6 77 74
Higher secondary 175 66.1 191 61.8 250 77.6 211 74.3 196 73
Tertiary 188 75.1 234 73 311 82.3 243 81.9 285 83.4
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and 2013, with relative inequalities increasing by 32.8%
(p = 0.03). In Wallonia, the observed fluctuations (Fig. 4a
and b) in RII and SII between 1997 and 2013 were not
significant.
Discussion
Using repeated cross-sectional data from five successive
waves (1997–2001–2004-2008-2013) of the BHIS, this
study examines the diffusion patterns of mammogram
and Pap smear use in Belgium between 1997 and 2013,
in addition to exploring the possible impact of regional
screening policies in Flanders and Wallonia on the de-
velopment of educational inequalities in mammogram
and Pap smear use over time.
One finding with respect to the diffusion of Pap smear
use was that the proportion of women who indicated
Fig. 1 a Diffusion of mammogram use in women 50–69 years old between 1997 and 2013, by region. b Diffusion of mammogram use in women
50–69 years old between 1997 and 2013 in Flanders, by educational level. c Diffusion of mammogram use in women 50–69 years old between
1997 and 2013 in Wallonia, by educational level
Fig. 2 a Diffusion of Pap smear use in women 25–64 years old between 1997 and 2013, by region. b Diffusion of Pap smear use in women 25–64
years old between 1997 and 2013 in Flanders, by educational level. c Diffusion of Pap smear use in women 25–64 years old between 1997 and 2013 in
Wallonia, by educational level
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Fig. 3 a Relative index of inequality (RII) for mammogram use, by region and survey year. b Slope index of inequality (SII) for mammogram use,
by region and survey year
Table 2 Development in the relative index of inequality (RII) and the slope index of inequality (SII) a for mammogram and Pap
smear use in women 50–69 and 25–64 years old, respectively, in Flanders and Wallonia, across the five waves of the BHIS (1997–
2013)
RII (95% CI) SII (95% CI) RII (95% CI) SII (95% CI)
Mammogram use in Flanders (N = 2075) Mammogram use in Wallonia (N = 2119)
1997 2.09 (1.32–3.31) ** 28.90 (10.94–48.65) ** 1.21 (0.84–1.75) 15.02 (−6.67–36.71)
2001 1.15 (0.84–1.37) 10.19 (−10.06–30.44) 1.76 (1.33–2.34) *** 38.82 (20.69–56.95) ***
2004 1.37 (1.07–1.75) * 23.84 (6.48–41.19) ** 1.35 (1.11–1.66) ** 23.65 (8.33–38.98) **
2008 1.15 (0.92–1.43) 10.39 (−6.51–27.3) 1.2 (0.96–1.5) 14.55 (−2.26–31.37)
2013 1.27 (1.03–1.56) * 18.86 (1.98–35.74) * 1.17 (0.89–1.55) 11.03 (−11.83–32.24)
Successive changes Change p-value b Change p-value b Change p-value b Change p-value b
2001 vs. 1997 −45.0% 0.04 * − 64.7% 0.18 45.5% 0.1 158.5% 0.1
2004 vs. 2001 19.1% 0.42 133.9% 0.32 −23.3% 0.11 −39.1% 0.21
2008 vs. 2004 −16.1% 0.28 −56.4% 0.28 −11.1% 0.44 −38.5% 0.44
2013 vs. 2008 10.4% 0.51 81.5% 0.49 −2.5% 0.89 −24.2% 0.8
Overall change Change p-value b Change p-value a Change p-value b Change p-value b
2013 vs. 1997 −39.2% 0.05 * −34.7% 0.44 −3.3% 0.88 −26.6% 0.8
Pap smear use in Flanders (N = 4405) Pap smear use in Wallonia (N = 4583)
1997 1.19 (1–1.41 * 12.42 (−0.36–25.2) 1.46 (1.19–1.8) *** 23.95 (10.26–37.65) ***
2001 1.25 (1.06–1.48) ** 15.28 (2.57–28) * 1.64 (1.37–1.98) *** 33.62 (21.14–46.1) ***
2004 1.39 (1.16–1.66) *** 25.03 (11.74–38.32) *** 1.38 (1.19–1.6) *** 23.71 (12.55–34.87) ***
2008 1.25 (1.03–1.53) * 18.22 (3.55–32.88) * 1.18 (1.01–1.39) * 12.77 (0.39–25.16) *
2013 1.58 (1.3–1.92) *** 32.28 (19.78–44.7) *** 1.2 (1.01–1.42) * 13.34 (0.01–26.67) *
Successive changes Change p-value b Change p-value b Change p-value b Change p-value b
2001 vs. 1997 5.0% 0.68 23.0% 0.76 12.3% 0.41 40.4% 0.31
2004 vs. 2001 11.2% 0.4 63.7% 0.3 −15.9% 0.15 −29.5% 0.25
2008 vs. 2004 −10.1% 0.45 −27.2% 0.5 −14.5% 0.17 −46.1% 0.2
2013 vs. 2008 26.4% 0.05 * 77.2% 0.15 1.7% 0.92 4.4% 0.95
Overall change Change p-value b Change p-value b Change p-value b Change p-value b
2013 vs. 1997 32.8% 0.03 ** 159.9% 0.03 * −17.8% 0.14 −44.3% 0.28
aRII and SII values are adjusted for age, country of birth, urbanisation, employment status, necessity of postponing medical consumption and difficulty
contributing to healthcare
bp-value of the t-test of Altman and Bland on a difference between measures of two different survey years
* p < .050; ** p < .010; *** p < .001
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that they had been screened in the past three years
hardly changed at all over time. On average, coverage
was relatively high (70%), although it was still below the
generally accepted European target of 75%. This target
was reached only in Wallonia, with a coverage of 76% in
2013. Second, in both Flanders and Wallonia, where Pap
smear tests were offered predominantly in an opportun-
istic manner, we found large and persistent educational
inequalities in Pap smear use between 1997 and 2013.
This finding is in line with previous studies that have
highlighted the disadvantages of opportunistic screening
in terms of efficiency, quality and equal use [6, 7, 9, 20,
32, 33]. On the one hand, the relatively high rate of Pap
smear coverage in Flanders and Wallonia indicates a rea-
sonable degree of spread throughout the population. On
the other hand, between 1997 and 2013, consistently
more women with high than with low levels of education
reported having had a Pap smear in the past three years.
This finding is in contradiction to the diffusion pattern
predicted by DOI theory. Based on this theory, we ex-
pected that Pap smears would initially be accessed by
women with higher levels of education, causing an in-
creasing gap in use, which would eventually narrow as
the screening test became increasingly widespread
within the population and people with lower levels of
education caught up with their more highly educated
counterparts [48].
The deviation from the diffusion pattern predicted by
DOI theory might have been due to a common
phenomenon within the context of opportunistic
screening that also occurs in Belgium: the combination
of over-screening and unequal screening, due to
under-screening amongst a portion of the eligible
women [30, 31]. In every survey year between 1997 and
2013, women with lower levels of education were less
likely to report having had a Pap smear in the past three
years, as compared to women with higher levels of edu-
cation. This pattern was observed in both Flanders and
Wallonia. Moreover, the efforts of both regional govern-
ments to address the problem of over-consumption by
gradually reducing the reimbursement of Pap smears to
once every three years did not seem to have paid off in
Flanders. On the contrary, according to our results, both
absolute and relative educational inequalities in Pap
smear use in Flanders increased significantly between
1997 and 2013, with the greatest increase in relative in-
equality occurring between 2008 and 2013. In Flanders,
therefore, the reduced reimbursement of Pap smears pri-
marily affected less-educated women, amongst whom
Pap smear use had clearly decreased in the three preced-
ing years.
With regard to the diffusion of mammogram use, our
findings were in line with DOI theory, with this screen-
ing test clearly becoming increasingly widespread within
the eligible population over time (between 1997 and
2013) in both Flanders and Wallonia. In Wallonia, how-
ever, mammogram use increased only until 2008, after
which it exhibited a remarkable decline. As revealed by
an outline of the diffusion patterns by educational level
for Wallonia, this decline could be attributed to a de-
crease in mammogram use in the preceding two years
by women with tertiary education, as well as by those
who had completed no more than primary education.
The growing controversy over mammography screening
may have played a role in the declines revealed in our
results. Despite European guidelines, mammography
screening continues to be a widely debated prevention
strategy [49]. More specifically, the debate reflects a con-
sideration between the harmful effects at the individual
level (e.g. pain when the mammogram is taken [50], fear
and psychological distress caused by false positives [51]
and over-diagnosis and over-treatment of breast cancers
that would otherwise not be diagnosed during a woman’s
life [49, 52]) and the benefits at the population level (e.g.
a reduction of 20–30% breast cancer mortality amongst
women between the ages of 50 and 69 years [53, 54]). It
Fig. 4 a Relative index of inequality (RII) for Pap smear use, by region and survey year. b Slope index of inequality (SII) for Pap smear use,
by region and survey year
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is possible that the mammography controversy is more
pronounced in the south of Belgium, where the greater
prevalence of opportunistic screening might increase the
likelihood that information on this issue is disseminated
by gynaecologists and general practitioners. In Wallonia,
gynaecologists play the most important role in encour-
aging women to have mammograms, while general prac-
titioners are crucial for women with low levels of
education [55]. Moreover, perceptions of ambiguity re-
garding cancer screening have been associated with di-
minished uptake [56–59]. In particular, people with
lower levels of education have been found to exhibit
higher levels of ambiguity aversion (i.e. when ambiguity
is high, they pessimistically appraise the risks and bene-
fits of action and avoid decision-making) [57, 60, 56]. As
suggested by Han and colleagues [60], higher educa-
tional attainment might affect perceived ambiguity by
enhancing the capacity of individuals to make sense of
conflicting health information. In the same vein, Mir-
owsky and Ross [61] report that people with higher
levels of education tend to have a greater capacity to
make sense of conflicting health information. Results
from a study conducted in the Netherlands amongst
women who were invited for breast cancer screening for
the first time do indeed suggest higher levels of sufficient
knowledge and informed choice in women with higher
levels of education [62]. It is therefore plausible that, in
Wallonia, the reduction in mammogram use amongst
more highly educated women resulted from informed
and conscious choices, with ambiguity aversion playing a
greater role in the diminished use amongst women with
less education.
At the outset of this study, we suggested that govern-
ment policies (and, more specifically, the introduction of
the national breast cancer screening programme in 2001
in Flanders and in 2002 in Wallonia) could have had an
impact on the diffusion of mammogram use and the
associated educational inequalities. In light of previous
research noting that most Walloon women are screened
in an opportunistic manner outside the screening
programme during consultations with their general prac-
titioners or gynaecologists, we also expected that the
different screening climates of Flanders and Wallonia
would be reflected in different patterns of diffusion. Ac-
cording to our results, in 1997, educational inequalities
were lower in Wallonia than they were in Flanders. By
charting developments over time, however, it became
clear that, in Wallonia, despite the implementation of
the national screening programme in 2002, educational
inequalities in mammogram use did not change signifi-
cantly between 1997 and 2013. In contrast, in Flanders,
educational inequalities decreased significantly between
1997 and 2001, when the screening programme was
launched, with an overall decline being observed
between 1997 and 2013. Consistent with our assump-
tions, the national breast cancer screening programme
in Flanders advanced the diffusion of mammogram use
within the population and reduced, although it did not
eliminate the educational inequalities in mammogram
use, while this was not the case in Wallonia.
Limitations
This study provides valuable new insight into the impact
of regional screening policies on the development of
educational inequalities in Pap smear and mammogram
use in Belgium. It is nevertheless subject to several limi-
tations. First, the health-interview data on which the
study is based have several weak points. Mammogram
and Pap smear use are based on self-reported informa-
tion, which might be subject to recall bias, and particular
to an overestimation of use, as people tend to underesti-
mate the length of time since they last had a mammo-
gram or Pap smear. Comparison with data from the
National Institute for Social Security has indeed demon-
strated that the BHIS data overestimate the overall
coverage of mammogram and Pap smear use [55].
Nevertheless, the BHIS remains an important source of
information, as it offers the unique opportunity to exam-
ine developments in cancer screening coverage over
time, as well as the relationship of such developments
with several socio-economic parameters, which are not
available or suitable in the data from the National Insti-
tute for Social Security. Moreover, linking of the 2008
BHIS data to data from the insurance institutions has
demonstrated that the validity of the BHIS data (in
terms of sensitivity and specificity) does not vary signifi-
cantly by level of education. Another weak point of the
BHIS is its lack of detailed information regarding
non-participation. This prevented us from assessing bias
related to socioeconomic status. Previous research on
health-interview data has indicated that lower socioeco-
nomic groups tend to have a higher non-response rates
on items relating to cancer screening and subjective
health [63]. The data used in this study might therefore
underestimate inequalities in mammography and Pap
smear use with regard to poorer uptake amongst lower
socioeconomic groups.
Second, although the repeated cross-sectional research
design made it possible to draw conclusions on how the
use of screening tests amongst women with high and
low levels of education have changed over time, it ham-
pered the causal interpretation of the results. Nonethe-
less, previous studies have provided compelling evidence
of a causal relationship running from more schooling to
better health [64–66]. Additionally, in the current study,
all outcomes occurred after the respondents had com-
pleted their education.
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Third, we advanced educational attainment as the
main mechanism of stratification, as the knowledge and
skills acquired during education could make people
more receptive to health information, in addition to
making them better equipped to obtain these messages
and access appropriate health services [61]. Moreover, in
contrast to other stratification indicators (e.g. type of
employment and income), educational level is more
stable over time, and information on this characteristic
is largely available for almost all of the women in the
study. Our statistical models nevertheless accounted for
indicators relating to employment and income by in-
cluding work status, as well as the necessity of postpon-
ing medical consumption and difficulties in contributing
to healthcare. In addition, and similar to the study by
Renard and colleagues [5], a sensitivity analysis using in-
come level (available only at the household level) as an
indicator of stratification did not demonstrate the same
effects, nor did it reveal any clear time-pattern of the in-
equalities. In addition to the higher level of missing an-
swers (N = 507; 13.7%), it is plausible that household
income level captures aspects of women’s social position
other than their individual educational level, and that
those indicators are not interchangeable. This should be
investigated more in detail, but doing so would have
exceeded the scope of this study.
Fourth, given that this study focuses only on
Belgium, the generalisability of the results could be
questioned. This study thus paves the way for future
studies investigating whether our findings also apply
in other national contexts.
Conclusions
We can conclude that, with regard to cancer screening
in Belgium, diffusion patterns vary by cancer screening
strategy and regional screening policy. In the case of
opportunistic screening, which was the strategy for of-
fering Pap smears in Flanders and Wallonia between
1997 and 2013, diffusion patterns did not reflect those
predicted by DOI theory. An outline of diffusion pat-
terns according to educational level reveals that the
relatively large extent of Pap smear use in Flanders and
Wallonia between 1997 and 2013 was accompanied by
consistently high educational inequalities in use over
time. The results of this study thus emphasise the po-
tential drawbacks of opportunistic screening in terms
of over-screening (i.e. well diffused use within the eli-
gible population, albeit only in the highly educated seg-
ment, due to their excessive screening behaviour).
By highlighting the impact of regional screening pol-
icies, this study demonstrates that the diffusion of cancer
screening can contribute to equality in participation over
time, under the influence of an organised screening
programme, but only if the programme occupies a
prominent place amongst the available screening op-
tions. As revealed by our examination of the Belgian
case, a screening programme cannot be efficient and re-
duce or eliminate educational inequalities in screening
unless it is promoted by and conducted in cooperation
with general practitioners and gynaecologists. Despite its
national character, Flanders and Wallonia approached
their organised breast cancer screening programmes dif-
ferently, and these differences were reflected in differ-
ences in the development of educational inequalities in
mammogram use. This calls the effectiveness of the
Belgian programme into question. More specifically, al-
though the screening programme in Flanders certainly
has the potential to reduce educational inequalities in
use, additional effort is needed in order to eliminate all
disparities between women with low and high levels of
education. The findings reveal a different situation in
Wallonia, where widespread opportunistic screening
competed with the organised screening programme. This
apparently impeded the effective functioning of the orga-
nised programme, as well as its positive impact on the
education gradient in mammogram use.
In summary, by applying DOI theory to inequalities in
cancer screening in a regionally variating context, this
study highlights two aspects that should be addressed in
future research: [1] the possibility that, in the case of an
opportunistic screening strategy, widespread use can
imply an underlying problem of over-screening and as-
sociated disparities in use, and [2] the possibility that re-
gional variations in support of a national screening
programme can result in regional variation in patterns
of diffusion for cancer screenings, as well as in the de-
velopment of inequalities in use.
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